Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
McGorry, Patrick
Killackey, Eoin
Elkins, Kathryn
Lambert, Martin
and
Lambert, Tim
2003.
Summary Australian and New Zealand Clinical Practice Guideline for the Treatment of Schizophrenia 2003.
Australasian Psychiatry,
Vol. 11,
Issue. 2,
p.
136.
Wright, Padraig
Lindborg, Stacy R
Birkett, Martin
Meehan, Karena
Jones, Barry
Alaka, Karla
Ferchland-Howe, Iris
Pickard, Anne
Taylor, Cindy C
Roth, John
Battaglia, John
Bitter, István
Chouinard, Guy
Morris, Philip LP
and
Breier, Alan
2003.
Intramuscular Olanzapine and Intramuscular Haloperidol in Acute Schizophrenia: Antipsychotic Efficacy and Extrapyramidal Safety during the First 24 Hours of Treatment.
The Canadian Journal of Psychiatry,
Vol. 48,
Issue. 11,
p.
716.
Srinivasan Tirupati, N.
Rangaswamy, Thara
and
Raman, Padmavati
2004.
Duration of Untreated Psychosis and Treatment Outcome in Schizophrenia Patients Untreated for Many Years.
Australian & New Zealand Journal of Psychiatry,
Vol. 38,
Issue. 5,
p.
339.
Shaw, Mike
and
Singh, Swaran P
2004.
Management of early-onset psychosis.
Current Opinion in Psychiatry,
Vol. 17,
Issue. 4,
p.
249.
Théberge, Jean
Al-Semaan, Yousef
Drost, Dick J
Malla, Ashok K
Neufeld, Richard W.J
Bartha, Robert
Manchanda, Rahul
Menon, Ravi
Densmore, Maria
Schaefer, Betsy
and
Williamson, Peter C
2004.
Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
Psychiatry Research: Neuroimaging,
Vol. 131,
Issue. 2,
p.
107.
Üçok, Alp
Polat, Aslιhan
Genç, Aysun
Çakιr, Sibel
and
Turan, Nurten
2004.
Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia.
Journal of Psychiatric Research,
Vol. 38,
Issue. 2,
p.
163.
Thornicroft, Graham
and
Tansella, Michele
2004.
Components of a modern mental health service: a pragmatic balance of community and hospital care.
British Journal of Psychiatry,
Vol. 185,
Issue. 4,
p.
283.
Krebs, Marie-Odile
and
Canceil, Olivier
2004.
Détection précoce des troubles psychotiques : enjeux de la mise en place d'un réseau de soins.
Revue française des affaires sociales,
p.
91.
Tirupati, N. Srinivasan
Rangaswamy, Thara
and
Raman, Padmavati
2004.
Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years.
Australian and New Zealand Journal of Psychiatry,
Vol. 38,
Issue. 5,
p.
339.
Krstev, Helen
Carbone, Steve
Harrigan, Susy M.
Curry, Christina
Elkins, Kathryn
and
McGorry, Patrick D.
2004.
Early intervention in first-episode psychosis.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 39,
Issue. 9,
p.
711.
Hodgson, Richard
Belgamwar, R.
Al-tawarah, Yasin
and
MacKenzie, G.
2005.
The use of atypical antipsychotics in the treatment of schizophrenia in North Staffordshire.
Human Psychopharmacology: Clinical and Experimental,
Vol. 20,
Issue. 2,
p.
141.
Drake, Richard J
and
Lewis, Shôn W
2005.
Early detection of schizophrenia.
Current Opinion in Psychiatry,
Vol. 18,
Issue. 2,
p.
147.
Norman, Ross M. G.
Lewis, Shôn W
and
Marshall, Max
2005.
Duration of untreated psychosis and its relationship to clinical outcome.
British Journal of Psychiatry,
Vol. 187,
Issue. S48,
p.
s19.
Lewis, Shôn W.
Tarrier, Nicolas
and
Drake, Richard James
2005.
Integrating non-drug treatments in early schizophrenia.
British Journal of Psychiatry,
Vol. 187,
Issue. S48,
p.
s65.
2005.
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the Treatment of Schizophrenia and Related Disorders.
Australian & New Zealand Journal of Psychiatry,
Vol. 39,
Issue. 1-2,
p.
1.
Cirulli, Giovanni
2005.
Clozapine prescribing in adolescent psychiatry: survey of prescribing practice in in-patient units.
Psychiatric Bulletin,
Vol. 29,
Issue. 10,
p.
377.
Cadenhead, Kristin S.
Light, Gregory A.
Shafer, Kathleen M.
and
Braff, David L.
2005.
P50 Suppression in Individuals at Risk for Schizophrenia: The Convergence of Clinical, Familial, and Vulnerability Marker Risk Assessment.
Biological Psychiatry,
Vol. 57,
Issue. 12,
p.
1504.
Yu-Hai Chen, Eric
Dunn, Eva Lai-Wah
Miao, May Yin-King
Yeung, Wai-Song
Wong, Chi-Keung
Chan, Wah-Fat
Yuk-Lun Chen, Ronald
Chung, Ka-Fai
and
Tang, Wai-Nang
2005.
The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 40,
Issue. 5,
p.
350.
Olié, Jean-Pierre
Lôo, Henri
and
Krebs, Marie-Odile
2005.
Schizophrénies : actualités étiopathogéniques et cliniques.
Bulletin de l'Académie Nationale de Médecine,
Vol. 189,
Issue. 5,
p.
935.
Caton, C. L. M.
Hasin, D. S.
Shrout, P. E.
Drake, R. E.
Dominguez, B.
Samet, S.
and
Schanzer, B.
2005.
Predictors of Psychosis Remission in Psychotic Disorders That Co-occur With Substance Use.
Schizophrenia Bulletin,
Vol. 32,
Issue. 4,
p.
618.